Grimm, Oliver https://orcid.org/0000-0002-0767-0301
Nägele, Magdalena
Küpper-Tetzel, Lea
de Greck, Moritz
Plichta, Michael
Reif, Andreas
Funding for this research was provided by:
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Received: 24 March 2020
Accepted: 23 October 2020
First Online: 2 November 2020
Compliance with ethical standards
: The project was carried out in accordance with the provisions of the Declaration of Helsinki and the European guidelines on Good Clinical Practice and was approved by the Ethics Committee of the Medical Faculty of the J.W. Goethe University Frankfurt am Main (reg. no. 256/16). The study was registered in the German register of clinical studies since on November 11, 2016, with the study ID DRKS00011209.56. Subjects gave written informed consent.
: The authors are solely <i>responsible</i> for the content of this publication. It does not represent the opinion of the <i>EC, and the EC is not responsible for any use</i> of data provided in this paper.
: Prof. Dr. Andreas Reif received personal fees from MEDICE Arzneimittel Pütter GmbH & Co. KG, Shire PLC, Neuraxpharm Arzneimittel GmbH, Janssen-Cilag GmbH, and Servier Deutschland GmbH presently or during 36 months prior to publication. Oliver Grimm received personal fees from MEDICE Arzneimittel Pütter GmbH & Co. KG. No other competing interests are disclaimed.